257 related articles for article (PubMed ID: 15736160)
1. Abnormal kinetic behavior of uroporphyrinogen decarboxylase obtained from rats with hexachlorobenzene-induced porphyria.
Chaufan G; Corvi MM; San Martín de Viale LC; Cárdenas ML; Ríos de Molina Mdel C
J Biochem Mol Toxicol; 2005; 19(1):19-24. PubMed ID: 15736160
[TBL] [Abstract][Full Text] [Related]
2. Liver porphyrinogen carboxylase in hexachlorobenzene porphyric rats. Studies with intermediate porphyrinogens of series III and with uroporphyrinogen I.
Ríos de Molina MC; Wainstok de Calmanovici R; San Martín de Viale LC
Int J Biochem; 1987; 19(4):365-72. PubMed ID: 3595984
[TBL] [Abstract][Full Text] [Related]
3. Investigations of rat liver uroporphyrinogen decarboxylase. Comparisons of porphyrinogens I and III as substrates and the inhibition by porphyrins.
Smith AG; Francis JE
Biochem J; 1981 Apr; 195(1):241-50. PubMed ID: 7306050
[TBL] [Abstract][Full Text] [Related]
4. Porphyria-induced hepatic porphyrinogen carboxy-lyase inhibitor and its interaction with the active site(s) of the enzyme.
de Catabbi SB; de Calmanovici RW; Minutolo C; Aldonatti C; San Martin de Viale LC
Biochem Mol Biol Int; 1999 Jun; 47(6):945-56. PubMed ID: 10410240
[TBL] [Abstract][Full Text] [Related]
5. Tetrapyrroles as substrates and inhibitors of porphyrinogen carboxy - lyase from rat liver.
San Martín de Viale LC; Aragonés A; Tomio JM
Acta Physiol Lat Am; 1976; 26(5):403-14. PubMed ID: 1052603
[TBL] [Abstract][Full Text] [Related]
6. The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase.
Kushner JP; Steinmuller DP; Lee GR
J Clin Invest; 1975 Sep; 56(3):661-7. PubMed ID: 1159079
[TBL] [Abstract][Full Text] [Related]
7. The role of iron in the hexachlorobenzene induced porphyria. I. Studies on different types of iron and its relation with porphyrinogen carboxy-lyase decrease.
Wainstok de Calmanovici R; Ríos de Molina MC; San Martín de Viale LC
Acta Physiol Pharmacol Latinoam; 1985; 35(4):481-91. PubMed ID: 2940809
[TBL] [Abstract][Full Text] [Related]
8. Some kinetic properties of human red cell uroporphyrinogen decarboxylase.
de Verneuil H; Grandchamp B; Nordmann Y
Biochim Biophys Acta; 1980 Jan; 611(1):174-86. PubMed ID: 7350915
[TBL] [Abstract][Full Text] [Related]
9. Immunochemical studies of the uroporphyrinogen decarboxylase defect caused by hexachlorobenzene.
Elder GH; Urquhart AJ
IARC Sci Publ; 1986; (77):441-8. PubMed ID: 3596736
[TBL] [Abstract][Full Text] [Related]
10. Studies on the mechanism of uroporphyrinogen decarboxylase inhibition in hexachlorobenzene-induced porphyria in the female rat.
Mylchreest E; Charbonneau M
Toxicol Appl Pharmacol; 1997 Jul; 145(1):23-33. PubMed ID: 9221820
[TBL] [Abstract][Full Text] [Related]
11. Porphyrins and porphyrinogen carboxy-lase in hexachlorobenzene-induced porphyria.
San Martín De Viale LC; Ríos De Molina MD; De Calmanovici RW; Tomio JM
Biochem J; 1977 Dec; 168(3):393-400. PubMed ID: 606243
[TBL] [Abstract][Full Text] [Related]
12. Relative abilities on a molar basis of hexafluoro-, hexachloro- and hexabromobenzenes to decrease liver uroporphyrinogen decarboxylase activity and cause porphyria in female rats.
Smith AG; Francis JE
Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):377-84. PubMed ID: 7394329
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactive uroporphyrinogen decarboxylase is unchanged in porphyria caused by TCDD and hexachlorobenzene.
Elder GH; Sheppard DM
Biochem Biophys Res Commun; 1982 Nov; 109(1):113-20. PubMed ID: 7159416
[No Abstract] [Full Text] [Related]
14. Random decarboxylation of uroporphyrinogen III by human hepatic uroporphyrinogen decarboxylase.
Luo JL; Lim CK
J Chromatogr; 1991 May; 566(2):409-13. PubMed ID: 1939452
[TBL] [Abstract][Full Text] [Related]
15. The effect of the porphyrogenic compound, hexachlorobenzene, on the activity of hepatic uroporphyrinogen decarboxylase in the rat.
Elder GH; Evans JO; Matlin SA
Clin Sci Mol Med; 1976 Jul; 51(1):71-80. PubMed ID: 939068
[TBL] [Abstract][Full Text] [Related]
16. Hepatic uroporphyrin accumulation and uroporphyrinogen decarboxylase activity in cultured chick-embryo hepatocytes and in Japanese quail (Coturnix coturnix japonica) and mice treated with polyhalogenated aromatic compounds.
Lambrecht RW; Sinclair PR; Bement WJ; Sinclair JF; Carpenter HM; Buhler DR; Urquhart AJ; Elder GH
Biochem J; 1988 Jul; 253(1):131-8. PubMed ID: 3138981
[TBL] [Abstract][Full Text] [Related]
17. Decarboxylation of uroporphyrinogen III by erythrocyte uroporphyrinogen decarboxylase. Evidence for a random decarboxylation mechanism.
Luo J; Lim CK
Biochem J; 1990 Jun; 268(2):513-5. PubMed ID: 2363688
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda.
Franklin MR; Phillips JD; Kushner JP
Toxicol Appl Pharmacol; 1997 Dec; 147(2):289-99. PubMed ID: 9439724
[TBL] [Abstract][Full Text] [Related]
19. Decarboxylation of porphyrinogens by rat liver uroporphyrinogen decarboxylase.
Smith AG; Francis JE
Biochem J; 1979 Nov; 183(2):455-8. PubMed ID: 534506
[TBL] [Abstract][Full Text] [Related]
20. Heme metabolism after discontinued hexachlorobenzene administration in rats: possible irreversible changes and biomarker for hexachlorobenzene persistence.
De Catabbi SCB ; Aldonatti C; de Viale LC
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Sep; 127(2):165-75. PubMed ID: 11083027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
